Molecular mimicry is a well-documented biological phenomenon and its link to autoimmune diseases has led to extensive research. From an epidemiological perspective, autoimmune diseases have been found to exhibit multifactorial origins. In most cases, genetic predisposition, as well as environmental factors leads to tissue injury owing to the activity of autoreactive antibodies or T cells. One of the most striking characteristics of autoimmune diseases is that the initial biological processes that lead to the loss of tolerance do not match with clinical manifestations. These manifestations occur long after the mechanisms associated with loss of tolerance. It is believed that loss of tolerance is responsible for the severity of chronic autoimmune diseases. Currently, there are several pathological processes involved in the breakdown of immunologic tolerance. These mechanisms include activation of polyclonal lymphocytes, abnormalities in self antigens presentation, molecular mimicry, and presence of autoreative lymphocytes (Bellone, 2005). In Crohn’s disease, as well as other autoimmune diseases such as ulcerative colitis, multiple sclerosis, and type 1 diabetes mellitus, molecular mimicry is hypothesized to be one of the key mechanisms leading to the breakdown of immunological self tolerance. Therefore, this paper will provide a comprehensive overview on molecular mimicry and its effects on autoimmune diseases with a principal focus on Crohn’s disease.
Table of Contents
1. Introduction to Molecular Mimicry
2. Mechanisms of Immunological Tolerance
3. Molecular Mimicry and Epitope Spreading
4. Role of Infectious Agents in Crohn's Disease
5. Genetic Factors and Pathophysiology
6. Clinical Perspectives and Challenges
Research Objectives and Themes
The primary objective of this paper is to provide a comprehensive scientific overview of molecular mimicry as a biological phenomenon and to evaluate its specific role in the pathogenesis and development of Crohn's disease through the breakdown of immunological self-tolerance.
- The intersection of molecular mimicry and autoimmune disease development.
- Mechanisms of central and peripheral tolerance and their failure.
- The role of specific pathogens, such as Klebsiella and Mycobacterium avium subsp. Paratuberculosis (MAP), in triggering Crohn's disease.
- Genetic predispositions and the interplay of T cell receptors in autoimmunity.
- Challenges in establishing microbial involvement in the etiopathology of chronic conditions.
Excerpt from the Book
Molecular Mimicry and Its Effect on Crohn's Disease
Molecular mimicry is a well-documented biological phenomenon and its link to autoimmune diseases has led to extensive research. From an epidemiological perspective, autoimmune diseases have been found to exhibit multifactorial origins. In most cases, genetic predisposition, as well as environmental factors leads to tissue injury owing to the activity of autoreactive antibodies or T cells. One of the most striking characteristics of autoimmune diseases is that the initial biological processes that lead to the loss of tolerance do not match with clinical manifestations. These manifestations occur long after the mechanisms associated with loss of tolerance. It is believed that loss of tolerance is responsible for the severity of chronic autoimmune diseases. Currently, there are several pathological processes involved in the breakdown of immunologic tolerance. These mechanisms include activation of polyclonal lymphocytes, abnormalities in self antigens presentation, molecular mimicry, and presence of autoreative lymphocytes (Bellone, 2005). In Crohn’s disease, as well as other autoimmune diseases such as ulcerative colitis, multiple sclerosis, and type 1 diabetes mellitus, molecular mimicry is hypothesized to be one of the key mechanisms leading to the breakdown of immunological self tolerance. Therefore, this paper will provide a comprehensive overview on molecular mimicry and its effects on autoimmune diseases with a principal focus on Crohn’s disease.
Summary of Chapters
1. Introduction to Molecular Mimicry: This chapter introduces the biological phenomenon of molecular mimicry and its hypothesized link to the breakdown of self-tolerance in various autoimmune conditions.
2. Mechanisms of Immunological Tolerance: This section explains how the human body maintains self-tolerance through central and peripheral mechanisms and how their failure leads to autoimmunity.
3. Molecular Mimicry and Epitope Spreading: This chapter details how secondary phenomena like epitope spreading and dual T cell receptor expression contribute to the persistence of autoimmune responses.
4. Role of Infectious Agents in Crohn's Disease: This section analyzes specific bacterial triggers, namely Klebsiella and MAP, and their role in initiating Crohn’s disease via molecular mimicry.
5. Genetic Factors and Pathophysiology: This chapter discusses genetic expressions and mutations (e.g., CARD15, MDR1) that increase susceptibility to Crohn's disease alongside the role of specialized T cells.
6. Clinical Perspectives and Challenges: The final chapter addresses the clinical difficulty of proving microbial etiopathology while summarizing the overall impact of molecular mimicry on autoimmune pathogenesis.
Keywords
Molecular Mimicry, Crohn's Disease, Autoimmunity, Immunological Tolerance, T cells, Pathogenesis, Epitope Spreading, Klebsiella, Mycobacterium avium subsp. Paratuberculosis, CARD15, Antigen Presentation, Autoantibodies, Immunologic Breakdown, Genetic Predisposition, Cytokines
Frequently Asked Questions
What is the core focus of this research paper?
The paper focuses on understanding molecular mimicry as a pathological mechanism that leads to the breakdown of immunological self-tolerance, specifically investigating its influence on the development of Crohn's disease.
What are the primary thematic areas covered?
Key themes include the biological definition of molecular mimicry, the protective role of immunological tolerance, the impact of bacterial infections, and the genetic markers associated with Crohn's disease.
What is the central research question?
The central question addresses how molecular mimicry acts as a fundamental mechanism in the etiology of autoimmune diseases, with a specific focus on the progression and clinical manifestations of Crohn's disease.
Which scientific methods or approaches are utilized?
The work employs a literature-based synthesis approach, analyzing clinical research, epidemiological data, and molecular studies regarding T cell responses and antigenic homology.
What specific topics are discussed in the main body?
The main body covers the mechanisms of central and peripheral tolerance, epitope spreading, the role of dual T cell receptors, specific infectious agents like Klebsiella and MAP, and the influence of key genes such as CARD15.
How can this work be characterized by its keywords?
The work is defined by terms relating to immunology, autoimmune pathogenesis, specific bacterial agents, and molecular genetic factors that interact during the progression of inflammatory bowel diseases.
How does Klebsiella pneumonia contribute to Crohn's disease according to the author?
The paper suggests that Klebsiella infections trigger the production of cross-reactive antibodies that interact with host tissues, leading to inflammatory cascades and pathological lesions associated with Crohn's disease.
What challenges are mentioned regarding the validation of microbial involvement?
The author highlights that it is difficult to satisfy Koch's postulates for autoimmune diseases, as clinical manifestations often appear long after the actual infectious event, complicating the causal link.
- Citar trabajo
- Patrick Kimuyu (Autor), 2018, Molecular Mimicry and Its Effect on Crohn's Disease, Múnich, GRIN Verlag, https://www.grin.com/document/388522
